Displaying 241 - 260 news posts of 1425
James Doty on the neuroscience of manifestation
In his new book, James Doty turns to the latest research findings in neuroscience to explain what manifestation does to the brain and body.
Psychedelics Inside Out: How do LSD and psilocybin alter perception? (Part 2)
This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain.
Augmented reality comes to regular glasses
By combining advances in display technologies, holographic imaging, and artificial intelligence, Stanford engineers have found a way to display full-color, 3D moving images over a direct view of the real world.
Exploring MRI's role in neuroscience research on model organisms
Recognizing the potential for wider application in small-animal neuroscience research, the Neurosciences Preclinical Imaging Lab (NPIL) at Wu Tsai Neuro hosted its 3rd annual symposium and named the recipients of its Pilot Grants.
Psychedelics, placebo, and anesthetic dreams
This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine.
Neuropsychiatry and sandwiches
Learn how a silo-busting program to probe neuropsychiatric disease was hatched over lunch with Wu Tsai Neuro affiliates Paul Nuyujukian, Karl Deisseroth, Carolyn Rodriguez, and Vivek Buch.
Why our brains are bad at climate change
This week on From Our Neurons to Yours, we're talking about the neuroscience of climate change with neuroeconomist Nik Sawe.
Brain organoids and assembloids are new models for elucidating, treating neurodevelopmental disorders
New research led by Wu Tsai Neuro affiliate Sergiu Pasca on Timothy syndrome may have implications beyond the rare genetic disorder — including conditions like schizophrenia. Supported by the Wu Tsai Neuro Big Ideas in Neuroscience grant program.
Alzheimer's drug adoption in US slowed by doctors' skepticism
Wu Tsai Neuro and Knight Initiative for Brain Resilience affiliate, Michael Greicius, and others share their expertise on the limitations of the Alzheimer's drug Leqembi.
Seven Stanford faculty named AAAS Fellows
Seven Stanford faculty, including Knight Initiative Director Tony Wyss-Coray, are among the 502 new fellows of the American Association for the Advancement of Science.
Stanford Medicine-led study identifies novel target for epilepsy treatment
A little-understood part of the brain appears to be involved in starting seizures and keeping them going, according to Wu Tsai Neuro affiliate Ivan Soltesz and team.
Could anesthesia-induced dreams wipe away trauma?
Cases of patients who recovered from trauma after dreaming under surgical anesthesia spur Wu Tsai Neuro affiliate Boris Heifets and his team to investigate dreaming as therapy.
Neuroscience sheds light on childhood gut disorders
The recent discovery that intestinal neurons normally self-organize into a striped pattern around the time of birth could help explain wide-ranging GI disorders in children, say Wu Tsai Neuro Faculty Scholar Julia Kaltschmidt and her team.
Imagining virtual reality as a simple tool to treat depression
Some of the 17 million Americans afflicted with major depressive disorder each year may soon receive a surprising new prescription from their clinician: Have fun on a virtual reality device.
Two key brain systems are central to psychosis, Stanford Medicine-led study finds
Inside the brains of people with psychosis, two key systems are malfunctioning: a “filter” that directs attention toward important external events and internal thoughts, and a “predictor” composed of pathways that anticipate rewards.
Why detecting the earliest biological signs of Parkinson’s disease is so crucial
Q&A with Wu Tsai Neuro affiliate Kathleen Poston about her work past and present on Parkinson’s disease. Poston studies the pathophysiology underlying the cognitive, behavioral and motor symptoms characteristic of Parkinson’s.
Spotlight: Lara Weed
Wu Tsai Neuro affiliate and NeuroTech alum Lara Weed was always interested in how the world worked, and looking back now, she can see her interest in performance optimization developing over time.
Phil Knight honored with Uncommon Citizen award
A dedicated philanthropist and Stanford GSB alum, Knight has provided game-changing support for schools and initiatives across campus.
Serious talk about moods with bipolar disorder expert Po Wang
We all get moody -- it's part of human nature. But if you have people in your life afflicted with bipolar disorder, you quickly realize that not all moodiness is created equally.
Research links age-related inflammation, microglia and Alzheimer’s Disease
Pro-inflammatory protein TREM1 in peripheral immune cells may promote age-related cognitive decline and dementia, according to Knight Initiative–funded research.